Obesity and Diabetes - NIH launches study to assess bariatric surgery in adolescents
Parkinson Disease - Jefferson participating in global study to extend effectiveness of drug for Parkinson's
Prostate Cancer - Curcumin, Also Known as Curry Powder, Has Anticancer Effects
Prostate Cancer - New imaging method shows whether treatment for advanced prostate cancer is working
Stem Cell Research - Stem cells provide new tool for studying disease and identifying ALS drugs
Surgery - NeuroArm: Navigating the future of surgery
Type 2 Diabetes - Standard long-acting insulin as good as newer medications
Wake Forest University - MS patients not receiving medications to slow disease progression, research shows
Access Pharmaceuticals, Inc. - Access Pharmaceuticals Signs Definitive Merger Agreement With Somanta Pharmaceuticals
Adverse Drug Reactions - Advanced Magnetics Announces Positive Results From Two Additional Phase III Studies of Ferumoxytol As an Intravenous Iron Replacement Therapeutic
Alzheimer Disease - Eisai Withdraw Application for Additional Indication of Aricept for Treatment of Severe Alzheimer's Disease in Europe
Alzheimer Disease - Neurochem Update on the North American Phase III Clinical Trial for Tramiprosate (ALZHEMED) for the Treatment of Alzheimer's Disease
Alzheimer Disease - Pre-Clinical Study Using Martek's DHA Reduces Brain Lesions in Alzheimer's Animal Model
Alzheimer Disease - Provista Life Sciences Announces the Opening of Its Clinical Laboratory - Provista Diagnostics (PDx)
Anemia - Data Analyses Outline Efficacy and Safety of MIRCERA for the Treatment of Renal Anemia Associated With Chronic Kidney Disease
Aneurysm - ev3's Onyx HD 500 Receives HDE Approval from FDA for Treatment of Cerebral Aneurysms
Angiogenesis - Abraxis BioScience Presents Data from Pre-Clinical Study That Provide Evidence for Chemotherapy-Induced Angiogenesis and Rationale for Combining nab-Paclitaxel (ABRAXANE) with Anti-Angiogenic Agent
Angiogenesis - AVN944 Shows Potent Antiproliferative Activity in Human Endothelial Cells
Angiogenesis - EntreMed Presents Multi-Mechanism Antitumor Data for ENMD-1420 in Preclinical Models
Angiogenesis - Lexicon Reports on Anti-Angiogenesis Target Discoveries
Angiogenesis - ZIOPHARM Presents Data Highlighting Oral ZIO-101 at AACR
Angioneurotic Edema - Dyax Initiates Confirmatory Phase 3 (EDEMA4) Trial for DX-88 for the Treatment of Hereditary Angioedema
Angioplasty - Cordis Corporation and ClearStream Technologies Group, plc, Sign Distribution Agreement for Peripheral Angioplasty Balloon Catheters
Antares Pharma, Inc. - Antares Pharma Announces Positive Results from Application Site Study for ANTUROL
Antisense Technology - Lorus Therapeutics Announces Scientific Presentations for Lead Antisense and siRNA Drug Candidates at International Cancer Conference
Antisense Technology - Novosom AG acquires exclusive option for CD40-targeted antisense inhibitors from Isis Pharmaceuticals
APR Applied Pharma Research - SANOFI-AVENTIS launches in the Belgian Market an innovative balsamic decongestant cream for Cough & Cold developed by APR Applied Pharma Research SA.
Arthritis - FDA Advisory Committee Recommends Against Approval for Merck's NDA for ARCOXIA (etoricoxib)
Arthritis - Merrimack Pharmaceuticals Initiates Enrollment in a Phase 2 Study of MM-093 in Patients with Rheumatoid Arthritis
Asthma - UnitedHealthcare Lowers Copayment for Chlorofluorocarbon-Free Brand-Name Inhalers in Response to Short Supplies and Higher Prices for Asthma Medication
Astigmatism - WaveLight Receives Wavefront-Guided and Mixed Astigmatism Approval for ALLEGRETTO WAVE Eye-Q
AstraZeneca - Alistair Darling MP, Secretary of State for Trade and Industry, Celebrates 'Golden Age' of Science and Innovation at AstraZeneca's Alderley Park Site
Atherosclerosis - First Patient Enrolled in Phase 2 'PLASMA' Trial With A-002 for Patients With Coronary Atherosclerosis
Autoimmune Disease - Critical Therapeutics Announces the Publication of New Preclincial HMGB1 Data in Nature Immunology
B-Cell Lymphoma - Data Presented at AACR Meeting Shows Peregrine's Immunocytokine Fusion Proteins Reduce Growth of B-Cell Lymphoma Tumors by 85% in Preclinical Studies
Behavior - Study Shows CDHP Financial Incentives Not Enough to Change Consumer Behavior
Best Practices, LLC - New Research Study Shows that Pharmaceutical Field Sales Reps' Productivity Inhibited by Unnecessary Internal Communication
BioInformatics, LLC - Winners of the 2007 Life Science Industry Awards Announced
BIOLASE Technology - BIOLASE Announces Preliminary First Quarter Results
BioMarin Pharmaceutical Inc. - BioMarin Announces Pricing of Public Offering of $282.5 Million Senior Subordinated Convertible Notes
BioMarin Pharmaceutical Inc. - BioMarin Announces Proposed Offering of $250 Million Senior Subordinated Convertible Notes
Biomedical Engineering - Accuri Cytometers Announces Completion of $5 Million Series B Financing Led By Baird Venture Partners
Biomedical Engineering - Beckman Coulter Proposed Acquisition of Biosite Passes Milestone With U.S. Regulatory Approval
Biomedical Engineering - Lifecore Biomedical Reports Results for Third Quarter Ended March 31, 2007
Biomet, Inc. - Biomet, Inc. Granted Continued Listing by NASDAQ
Bioscience - Amarillo Biosciences Rating Maintained at Speculative Buy by Dutton Associates
Bioscience - YM BioSciences' partner Daiichi Sankyo receives clearance for initial clinical trial in Japan
Biotech Business - 2007 BIO International Convention to Help Pave the Way for Emerging Companies
Biotech Business - A Window of Opportunity Opens for the Israeli Life Science Industry - June 2007 - Tel-Aviv
Biotech Business - Biotech Research and Development Will Benefit from Sarbanes-Oxley Changes
Biotech Business - Miller Canfield Opens Office in Cambridge, Mass.; Expands Biotechnology, IP and Life Sciences Practice
Biotech Business - Strategic Research Institute 11th Annual Conference to Address Issues of Pharmaceutical Outsourcing of Discovery Chemistry, Advanced Intermediates & APIs to All Levels of Pharma and Biotech Companies
Biotechnology - Affymax and Takeda Honored with the Allicense 2007 Breatkthrough Alliance Award for Their Exclusive Global Agreement for Hematide
Biotechnology - Congressman Van Hollen Honored as BIO Legislator of the Year
Biotechnology - Dr. Ganesh M. Kishore Joins Burrill & Company
Biotechnology - Global Biotechnology Makes Historic Advances
Biotechnology - Hercules Provides $3 Million of Venture Debt to NuGEN Technologies, a Biotechnology Company Specializing in Gene Expression Analysis
Biotechnology - PIC Consulting to Adopt Campbell Informatics' Avenio Engine for Global Pharmaceutical and Biotechnology Projects
Biotechnology - Senator Baucus Honored as BIO Legislator of the Year
Biotechnology - Solutions for Biotechnology Companies Featured at KGI's TMP Day
Biotechnology - Stephanie Monk Joins SunTech Medical
Biotechnology - Translational Research Forum to Explore Philanthropy and Drug Development At 2007 BIO International Convention
Bird Flu - Statement by Mike Leavitt, Secretary of Health and Human Services, on the Approval of the First U.S. Vaccine for Humans Against the Avian Influenza Virus H5N1
Bladder Cancer - Spectrum Pharmaceuticals Announces Data From Three Oncology Programs Presented at the American Association of Cancer Research Annual Meeting
Bone Research - Cytochroma and Genzyme settle lawsuit
Brachytherapy - IBt and IBA sign a distribution agreement IBt continues to expand its product range in field of radiation oncology
Breast Cancer - Bionovo Enrolls First Patient on Phase 1/2 Clinical Trial of BZL101 for the Treatment of Advanced Breast Cancer
Breast Cancer - ExonHit Therapeutics and bioMerieux Present Additional Results in Their Breast Cancer Blood Biomarkers Program
Breast Cancer - Experts Discuss Benefits of New SAVI Breast Cancer Treatment
Breast Cancer - Genomic Predictors Report Likely Response to Multiple Treatments in Breast Cancer
Breast Cancer - Overall Approximately 3 Million Women in the US Are Living With Breast Cancer
Breast Implants - $2 Billion U.S. Market for Aesthetic Devices and Therapies Set to Double in Next Four Years, According to a New Report from Medtech Insight/Windhover Information
Cancer - Abbott Researchers Focus on New Cutting-Edge Approaches in the Fight Against Cancer
Cancer - Abraxis BioScience Presents Results from Pre-Clinical Study That Demonstrates nab-Rapamycin's Robust Antitumor Properties and Ability to Target Intracellular Sites Such as the mTOR Pathway
Cancer - Access Pharmaceuticals Announces Poster Presentations on ProLindac at the American Association for Cancer Research 2007 Annual Meeting
Cancer - Adnexus Therapeutics Announces Presentation at the American Association for Cancer Research (AACR) on Clinical Product Candidate, CT-322
Cancer - Aeolus Pharmaceuticals' AEOL 10113 Demonstrates Potential as a Protector of Healthy Normal Cells from Cancer Radiation Therapy
Cancer - Affymetrix and NuGEN Announce Agreement to Co-market the NuGEN WT-Ovation FFPE System
Cancer - Affymetrix Launches Program to Advance Cancer Research
Cancer - Aranesp Phase 3 Study in Patients with Active Cancer Not Receiving Concurrent Chemotherapy or Radiotherapy Presented at AACR Annual Meeting
Cancer - Arius Announces First Quarter Fiscal 2007 Financial Results
Cancer - Array BioPharma Appoints Dr. Neil Spector to Its Scientific Advisory Board
Cancer - Arrowhead Subsidiaries Insert & Calando Present Data on Cyclosert Drug Delivery System at AACR Meeting
Cancer - Canine Cancer Cure - Human Cancer Benefit Effort Launched by MAF
Cancer - Charlie Rose Science Series Explores Developments in Cancer Research
Cancer - Chemokine Therapeutics Announces 2006 Financial and Operating Results
Cancer - Cyclacel Pharmaceuticals reports preclinical Seliciclib-Erlotinib synergy data at AACR
Cancer - Data Show SuperGen's Multi-Targeted Tyrosine Kinase Inhibitor Suppresses Critical Double-Stranded DNA Repair Protein, Rad51
Cancer - Eisai Announces Completion of Acquisition of Morphotek
Cancer - EntreMed Presents Multi-Mechanism Results for ENMD-1198 at AACR Annual Meeting
Cancer - Enzon's PEG-SN38 Shows Anti-Tumor Activity in Resistant Preclinical Tumor Models
Cancer - Erimos Pharmaceuticals Names Dr. Scott Mohrland as President and Chief Executive Officer
Cancer - MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE Molecule
Cancer - Metabasis Therapeutics Presents Results of a Clinical Study for Its Novel Liver-Targeted Product Candidate for the Treatment of HCC at American Association for Cancer Research
Cancer - Micromet and MedImmune Present Data From Preclinical Study of New BiTE Molecule Targeting CEA
Cancer - Myriad Genetics Presents Azixa's Mode of Action at AACR
Cancer - Novel Human Tissue Transgenic Cancer Model May Offer Significant Advance Toward Accurately Modeling Human Cancer
Cancer - Novelos Therapeutics and MUSC Present Two Posters at AACR 2007 Annual Meeting
Cancer - Nutritional Supplements Safe and Beneficial for Patients Undergoing Chemotherapy and Radiation Therapy
Cancer - Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with Bruton's Tyrosine Kinase Inhibitors
Cancer - Positive Results Prompt US National Cancer Institute to Make Gleevec Available To Patients in Post-Surgical GIST Study
Cancer - Poster on Cyclosert Drug Delivery Presented at AACR Meeting
Cancer - Pro-pharmaceuticals Issues Corporate Update
Cancer - Research and Markets: Ixabepilone is Predicted to Reach the Market in Late 2007 for the Second-Line Treatment of Patients with Metastatic Breast Cancer
Cancer - Research and Markets: Ticilimumab is Predicted to Reach the Market in Late 2007 for the Treatment of Metastatic Melanoma
Cancer - Stanford Receives Cancer Center Designation From NCI
Cancer - Syndax Pharmaceuticals, Inc. Licenses Selective Histone Deacetylase Inhibitor MS-275
Cancer - Thermo Fisher Scientific RNA Technology Enables Groundbreaking Discovery in Cancer Research
Cancer - TopoTarget enters into share purchase agreement for the acquisition of Apoxis SA and plans to raise new capital through an offer of new shares
Cancer - VioQuest Pharmaceuticals Announces Data Presentation for Its Akt Inhibitor VQD-002, at American Association for Cancer Research Annual Meeting
Cancer - Viventia Biotech generates novel human anti-cancer antibody, VB1-050, and identifies its novel target
Cancer - ZIOPHARM Presents Unique Mechanism Data for Indibulin at AACR
Cancer Research - Anadys Reports Preclinical Data Showing ANA773 Promotes Anti-Tumor Activity of Natural Killer Cells
Cancer Research - ART to preview pipeline of molecular imaging products at AACR meeting in Los Angeles
Cancer Research - AVN944 Biomarker Study Identifies Gene Signatures Important for Patient Stratification
Cancer Therapy - Idera Pharmaceuticals Announces Presentations of Preclinical Data on New Potential Oncology Applications of its TLR9 Agonists at AACR
Cancer Vaccines - Advaxis Completes Dosing and Enrollment of Third Cohort of Patients in Phase I/II Cervical Cancer Vaccine Trial
Cancer Vaccines - AVAX Technologies Presents Results of Phase I-II M-Vax Trial at Annual Meeting of American Association for Cancer Research
Cancer Vaccines - Data Presented at AACR Meeting Show Peregrine's Bavituximab Equivalent Can Generate Curative Immune Responses as Part of a Vaccine-Like Regimen in Preclinical Models of Aggressive Brain Cancer
Cancer Vaccines - Generex Biotechnology Vaccine Development Programs Presented at the Annual Meeting of the American Association for Cancer Research
Cancer Vaccines - Merck Submits New Cross-Protection Data for GARDASIL to the FDA and Seeks New Indications for Vaginal and Vulvar Cancers
Cancer Vaccines - Northwest Biotherapeutics Files for Authorization for Use of DCVax-Brain for Commercialization in Switzerland
Cancer Vaccines - Observant LLC Expands Senior Management Team
Cancer Vaccines - Roche and Transgene enter partnership on therapeutic vaccines against HPV-mediated diseases
Cardiology - Millipore Provides First L-type Calcium Channel for Drug Testing
Cardiology - The World Metabolic Syndrome Project Enters Collaboration With the European Society of Cardiology
Cardioprotection - Medicure Announces Third Quarter Fiscal 2007 Financial Results
Carl Icahn - Icahn Comments on MedImmune Sale Process
Celgene Corporation - Celgene Corporation to Announce First Quarter Results on May 3, 2007
Cell Biology - IDM Pharma Appoints Edward E. Penhoet, Ph.D to Board of Directors
Cell Biology - Invitrogen Garners Six Life Science Industry Awards
Cell Biology - TargeGen, Inc., Appoints Martin Friedlander, M.D., Ph.D. to Scientific Advisory Board
Cerebral Palsy - Dramatic Improvement for 19-Year-Old Hungarian Cerebral Palsy Sufferer After Stem Cell Treatment
Chronic Disease - DxCG Announces Strategic Alliance with BioSignia
Chronic Heart Failure - Vasogen and Grupo Ferrer Form Collaboration to Commercialize Celacade in the European Union
Chronic Myelogenous Leukemia - INNOVIVE Pharmaceuticals Announces Interim Phase I Data on INNO-406 for the Treatment of Gleevec-resistant or Intolerant Chronic Myelogenous Leukemia
Clinical Trial Research - Research and Markets: Telcyta was Predicted to Reach the Market by Mid-2007; However Phase III Results Do Not Support a Filing
Clinical Trial Research - S. Colin Neill Nominated to Pro-Pharmaceuticals Board of Directors
Clinical Trial Research - Sciele Begins to Enroll Patients in a Pivotal Phase III Clinical Trial for the Combination of Pravastatin and Fenofibrate
Clinical Trial Research - Web 2.0 Company Establishes New Marketplace for Sourcing Healthcare Alpha
Colon Cancer - ADVENTRX Announces Positive Data From Multidrug Therapy With CoFactor
Colon Cancer - Bioniche Presents Additional Data on the Anticancer Activity of MCC Against Peritoneal Carcinomatosis
Colon Cancer - Merck KGaA: Largest Ever Erbitux Trial Shows Significant Increase in Progression-Free Survival in Metastatic Colorectal Cancer Patients
Colon Cancer - Oncolytics Biotech Inc. Research Collaborators Demonstrate Reovirus/Gemcitabine Combination Has Synergistic Effect Against Human Colon Cancer Cell Lines
Colon Cancer - Randomized Phase III Trial Showed ERBITUX Significantly Improved Secondary Endpoints of Progression-Free Survival and Disease Control in Metastatic Colorectal Cancer Patients
Cord Blood - Cryo-Cell International, Inc. Reports First Quarter 2007 Results
Correctional Healthcare - America Service Group Announces Execution of Asset Purchase Agreement for the Sale of Certain Assets of Secure Pharmacy Plus
Cutting Edge Information - Average Customer Relationship Management Program takes 16.2 Months to Develop
Diabetes - Abbott Announces FDA Clearance and Launch of New FreeStyle Lite Blood Glucose Monitoring System
Diabetes - Metabolex Raises $32 Million to Accelerate Clinical Development Programs for Its Pipeline of Drug Candidates in Metabolic Disease
Diabetes - Nutrition 21 Announces Formation of Scientific Advisory Board
Diabetes - Regulatory Review Allows LCT Diabetes Clinical Program to Proceed
Diagnostic Assays - Increased Acceptance of PCR Technology Drives Growth in PCR Reagents Markets
Drug Delivery - As Transdermal Drug Delivery Gains Acceptance, Market Shoots to $7.9 Billion
Drug Delivery - MIV Therapeutics Highlights High-Growth Business Model, Next Generation Stent Technologies and Targeted $8 Billion Market in Updated Investor Fact Sheet
Drug Development - A Once-weekly Formulation of Risedronate Sodium Hydrate, an Antiosteoporotic Agent, Was Approved
Drug Development - AGI Therapeutics plc FDA approval to file IND for Arverapamil Phase III study
Drug Development - Bikash Chatterjee Leads Six Sigma Workshop at PDA Training and Research Institute in Indianapolis
Drug Development - BioSeek Awarded ToxCast Contract by EPA to Profile Chemicals for Toxicity Using BioMAP Assay Systems
Drug Development - Corning Introduces New Nanofiber Cell Culture Products
Drug Development - Dutton Associates Announces Investment Opinion: Provectus Pharmaceuticals Rating Maintained At Strong Speculative Buy By Dutton Associates
Drug Development - Eksigent Global Distribution Plans Forge Ahead in New Zealand and Australia
Drug Development - EPIX Pharmaceuticals Announces Statistically Significant Results in Cognitive Function from Phase 1b Clinical Trial of Novel 5-HT6 Drug Candidate
Drug Development - FDA Accepts GPC Biotech's Satraplatin NDA for Filing and Grants Priority Review Status
Drug Development - Galapagos signs two new drug discovery collaborations with Ono Pharmaceutical
Drug Development - Gene Logic Promotes Dr. Thomas Barnes to Lead Drug Repositioning Discovery Efforts
Drug Development - Helix BioMedix to Discuss Potential of Its Proprietary Peptides at the BIO International Convention
Drug Development - Indevus Announces Submission of Supplemental NDA to Reintroduce VALSTAR to Treat Bladder Cancer
Drug Development - IPS Opens Two Offices in India to Offer Clients Greater Access to Technical Engineering and Consulting Services
Drug Development - Micell Technologies Presents Data on Novel Drug-Eluting Stents
Drug Development - Molecular Devices Announces the Release of the First Live Cell Kinetic Neurotransmitter Transporter Uptake Assay Kit
Drug Development - Molecular Devices Introduces New Aequorin Option for Flipr Tetra Screening System
Drug Development - Mylan Announces Final FDA Approval for Glipizide and Metformin Hydrochloride Tablets
Drug Development - Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration Enters Development
Drug Development - PharmMD Helps Guard Against Medication Misuse, Overuse, Abuse
Drug Development - Pro-Pharmaceuticals Receives Letter from the FDA for New Drug Application for DAVANAT/5-FU
Drug Development - Renovo Announces Positive Phase II Efficacy Trial Results for Prevascar
Drug Development - SCOLR Pharma Announces Positive Ibuprofen Study Results and Status of Commercialization Program
Drug Development - Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
Drug Development - Statistics reported on the use of medicinal products and death rates in Denmark
Drug Development - Value of CDISC Standards Highlighted Through Business Case
Drug Development - VioQuest Pharmaceuticals Signs Definitive Agreement for Sale Valued Up to $3 Million of Chiral Quest Subsidiary
Drug Resistance - GSK Announces FDA Approval of Altabax (Retapamulin Ointment), 1%
Drug Safety - Large Numbers of People Are Not Very Confident in Their Own Knowledge and the Safety of Prescription Medications and This Often Leads to Non-Adherence
Drug Safety - Poll: Consumers Say Government Failed to Protect them from Dangerous Prescription Drugs; Americans Back Host of Drug Safety Reforms
Erythema - Senetek Initiates Clinical Trials of Pyratine 6 for Acne Rosacea
Experimental Therapeutics - Data Published in Neurology Showed That Higher Dose of COPAXONE Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS)
Federman & Sherwood - Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Amgen, Inc.
Female Infertility - Follistim introduced in Japan in a further indication for the treatment of infertility
Fibrosis - Nanogen Submits 510(K) for Cystic Fibrosis Genetic Assay and NanoChip 400 System
Fibrosis - Pharmaxis Begins Phase III Cystic Fibrosis Trial
Financials - Accuray Incorporated to Report Third Quarter Fiscal Year 2007 Financial Results on May 1, 2007
Financials - CareGuide Announces Improvement in Operating Results: Net Income of $69 Thousand and EBITDA of $3.3 Million for Nine Months Ended December 31, 2006
Financials - Dynacq Healthcare, Inc. Announces Reviewed Financial Results for the Fiscal Quarter Ended February 28, 2007
Financials - Fitch Rates Mother Frances Hospital (Texas) $90MM Series 2007 bonds 'BBB+'; Outlook Stable
Heart Disease - Medtronic Combines Vascular and Cardiac Surgery Businesses
Heart Disease - Schering-Plough Announces Initiation of Two Phase III Clinical Trials for Novel Selective Antiplatelet Therapy (TRA-SCH 530348)
Heart Failure - Boston Scientific Announces FDA Approval of Innovative Heart Failure Lead
Hepatitis B Virus - ANA380 Exhibits Activity In Vitro Against Multiple Clinically Relevant Hepatitis B Virus Mutants
Hepatitis B Virus - BARACLUDE (entecavir) Therapy Resulted in Undetectable Levels of Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment
Hepatitis C Virus - Achillion Presents Positive Data on Novel Mechanism for Treating HCV at EASL Annual Meeting
Hepatitis C Virus - Intarcia Therapeutics Announces Final Results From a Phase 2 Study of Injectable Omega Interferon plus Ribavirin for the Treatment of Hepatitis C Genotype-1
Hepatitis C Virus - Interim Results Presented at EASL from PROVE 1 Clinical Trial of Investigational Drug Telaprevir in Patients with Genotype 1 Hepatitis C
Hepatitis C Virus - Schering-Plough Addresses Major Milestones and Challenges in Treatment of Patients With Chronic Hepatitis C
Hepatitis C Virus - ViroPharma Announces Presentation of Additional HCV-796 Data at Meeting of the European Association for the Study of the Liver
HIV/AIDS - Avexa Secures CCR5 Inhibitor HIV Program With TargetDrug
HIV/AIDS - Koronis Pharmaceuticals Receives Notice of Allowance on Patent for Novel Therapeutic KP-1461 in Development for Treatment of HIV
HIV/AIDS - Millenia Hope Inc receives a grant from the National Institutes of Health (USA) to develop new HIV therapeutics in consortium with the University of Pittsburgh and Rutgers University
HIV/AIDS - Nutra Pharma Announces Successful Completion of Joint Venture Meetings in China
HIV/AIDS - What is the Estimated Value of the Brazilian Bioequivalent Generic Market Now & in 2012?
Homeopathy - Children and Adults With Attention Difficulties Find Safe Relief With New Homeopathic Product From VAXA International
Immunotherapy - Resistentia Initiates Phase II Clinical Testing of Novel Immunotherapeutic for Allergic Asthma
Implantable Devices - St. Jude Medical Announces FDA Approval of Internet-Based Data Management System for Implantable Cardiac Devices
Infusion Systems - Cardium Announces Automated Infusion System for Generx Phase 3 AWARE Study
Inogen, Inc. - Industry Veteran R. Scott Greer Joins Inogen Board
iVoice, Inc. - Thomas Pharmaceuticals Ltd. Files Registration Statement with SEC in Anticipation of Spin Off by iVoice, Inc. to its Shareholders
J.D. Power and Associates - J.D. Power and Associates Reports: Pharmacy Staff Interaction With Customers Strongly Impacts Overall Satisfaction With the Retail Pharmacy Experience
Johnson & Johnson - Johnson & Johnson Reports 2007 First-Quarter Results: Sales Increase of 15.7% and EPS of $.88 Versus $1.10 a Year Ago; Excluding Special Items, EPS was $1.16, an increase of 17.2 PERCENTSIG
Leukemia - Gemin X Presents Positive Preclinical Data of GX15-070 in Infant ALL at AACR Meeting
Leukemia - New Method Predicts Hip Joint Decay From Chemotherapy
Liver Cancer - Alnylam Announces Advancement of a New RNAi Therapeutic Development Program for the Treatment of Liver Cancer
Liver Cancer - Progen's Phase 2 Liver Cancer Trial Exceeds Efficacy Objective
Liver Cancer - Raptor Announces Fiscal Results, Updates Programs and Appoints Investor Relations Firm
Liver Cancer - Raptor Pharmaceuticals Corp. Announces Fiscal 2007 Second Quarter Results, Updates Programs and Appoints Investor Relations Firm
Lung Cancer - Data supporting three Antisoma programmes presented at AACR
Lung Cancer - Immunomedics Develops Novel Immunotoxin for Therapy of Prostate and Lung Cancers
Lung Cancer - Lung Cancer Alliance Hails FDA Decision to Expedite Treatment for Lung Cancer
Lung Cancer - Telik Reports Positive New TELCYTA Preclinical Data at American Association for Cancer Research Annual Meeting
Lupus - MedImmune Publishes New Data in Nature Immunology Demonstrating the Role HMGB1 May Play in Systemic Autoimmune Diseases
Lymphocytic Leukemia - Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in Cancer Animal Models
Lymphoma - Favrille Announces Results From Study Showing Enhanced Activity From Insect Cell-Derived Immunotherapy for Lymphoma
Lymphoma - ProNAi Announces Preclinical Success for PNT2258 Therapeutic - Curative Events in Xenograft Mice for Difficult-to-Treat Non-Hodgkin's Lymphoma
Lymphoma - Rigel Provides Clinical Update of R788 Phase 2 Trials in ITP, Rheumatoid Arthritis and Lymphoma
Medicare and Medicaid - Minority of Senate Blocks Vote to Allow Medicare to Negotiate Lower Drug Prices
Medicare and Medicaid - RxHub ePrescribing Standards Recommended for Use in Medicare Part D
Medicine Shoppe International, Inc. - Medicine Shoppe Pharmacies Rank Highest in J.D. Power and Associates Study of Retail Chain Pharmacy Customer Satisfaction
Melanoma - Genta Announces New Phase 3 Trial of Genasense in Patients with Advanced Melanoma
Melanoma - Viragen Announces European Multiferon Licensing Agreement
Menopause - K-State Research Shows Calcium Supplements Not Always Beneficial for Postmenopausal Women
Menstruation - Medicines regulator consults on widening the availability of a medicine for period pain
Merck & Co., Inc. - Merck Anticipates Higher Than Expected First-Quarter Results; Raises Full-Year 2007 Earnings Per Share Guidance
Mergers & Acquisitions - Biosite Announces Expiration of Hart-Scott-Rodino Waiting Period for Tender Offer With Beckman Coulter
Mergers & Acquisitions - Cegedim SA's Proposed Acquisition of Dendrite International, Inc. Clears U.S. Antitrust Review
Mergers & Acquisitions - MedAssets to Expand Revenue Cycle Suite Offering With Agreement to Acquire XactiMed
Monoclonal Antibodies - The Position of Monoclonal Antibodies on the Market is Solidly Poised for Growth with Six Novel Therapies Expected to Launch within the Next Five Years
Multiple Sclerosis - New One-Year Pharmacoeconomic Study Shows AVONEX is Cost-Effective Relative to Other Interferon Therapies for Multiple Sclerosis
Muscular Dystrophy - SynCo Bio Partners B.V. Signs Pharmaceutical Service Agreement With Prosensa B.V. for RNA Based Therapeutics for the Treatment of Duchenne Muscular Dystrophy
Myeloma - Millennium Discovers Biomarkers Potentially Predictive of Response to VELCADE (Bortezomib) for Injection
Myeloma - Sunesis Presents Data Supporting SNS-032's Potential Anticancer Activity in Multiple Myeloma at the American Association for Cancer Research Meeting
Myeloma - The International Myeloma Foundation Says CELGENE Launches New 'Patient Support Coordinator' Program at Meeting of Support Group Leaders in Phoenix
Myeloma - The Multiple Myeloma Research Consortium and Nereus Pharmaceuticals Initiate Clinical Trial Investigating NPI-0052 to Treat Multiple Myeloma
Nanotechnology - Abraxis BioScience Presents Pre-Clinical Findings That Support Role of SPARC Expression in Cancer and the Role of the Nanoparticle Albumin Bound (nab) Technology Platform in Targeting the Pathway
Nanotechnology - Lumera Launches Podcast Series Featuring Experts in Nanotechnology, Bio-Arrays, Electro-Optics and Wireless Technologies
Nanotechnology - Mark Davis To Moderate "novel Approaches To Drug Delivery In Cancer" Session At the Aacr Meeting
Nanotechnology - New Report Explores Nanotechnology's Future
NanoViricides, Inc. - NanoViricides Becomes a Member of Alliance for Biosecurity
Neurology - Cortex's AMPAKINE CX717 Toxicology Data Package Submitted to FDA
Neuropathic Pain - Avanir Pharmaceuticals Announces Positive Results of Phase III Study for Zenvia in Diabetic Neuropathic Pain
Neurotrauma - Boston Life Sciences, Inc. Announces Presentation of Cethrin Phase I/IIa 6-Month Results at 75th Annual Meeting of the American Association of Neurological Surgeons
Neutropenia - Lilly Oncology Focused on Pharmacogenomics at AACR Annual Meeting
Obesity and Diabetes - GTx Announces Ostarine Improved Insulin Resistance among Elderly Patients in a Recently Completed Phase II Clinical Trial
OMRIX Biopharmaceuticals, Inc. - OMRIX Biopharmaceuticals Announces First Quarter 2007 Financial Results Date and Conference Call
Oncology - Ingenuity Systems Releases IPA 5.0 Software, Offering New Biomarker and Molecular Toxicology Capabilities
Oramed Pharmaceuticals, Inc. - Exclusive Interview With Oramed Pharmaceuticals Inc. CEO, Nadav Kidron on www.Wallst.Net
Oscient Pharmaceuticals Corporation - Oscient Pharmaceuticals Announces Increase in Offering Size of New 3.50% Convertible Senior Notes Due 2011
Osteoporosis - Osteologix Completes Enrollment in Clinical Trial of Investigational Drug for Osteoporosis
Osteoporosis - The U.S. Food and Drug Administration Approves New Actonel Dose to Treat and Prevent Postmenopausal Osteoporosis
Ovarian Cancer - Ciphergen Biosystems Discovers Protein Biomarkers Useful for Diagnosis of Early-Stage Ovarian Cancer
Ovarian Cancer - Expression Genetics, Inc. Announces Successful Completion of Phase I Trial of Gene-Based IL-12 for Treatment of Ovarian Cancer
Pancreatic Cancer - Data Presented at AACR Meeting Shows Peregrine's Selective Anti-VEGF Antibodies are as Effective as Avastin in Preclinical Cancer Models
Parkinson Disease - SCHWARZ PHARMA Announces Publication of Rotigotine Data for Advanced Parkinson's Disease in Neurology
Partnership for Prescription Assistance - Partnership for Prescription Assistance Kicks Off New Effort to Connect Uninsured Children to Health Care Programs
Patents - Alphatec Holdings, Inc. Licenses Technology Focused On Minimally Invasive Spinal Surgery Market
Patents - Carrington and Primus Pharmaceuticals Sign Long-Term Supply and Patent Licensing Agreements for Acemannan Hydrogel
Patents - Dynogen to Receive Two Key European Patents for DDP733
Patents - FDA Confirms Mylan's Status as the Only Approved ANDA for all Strengths of Amlodipine Besylate Tablets
Patents - GPhA Calls PhRMA's Authorized Generics Study 'Disingenuous'
Patents - Osprey Pharmaceuticals Limited Announces Issuance of 3 U.S. Patents
Patents - Patent Granted In the US Which Further Increases Value of Duchenne Muscular Dystrophy Programme
Patents - RegeneRx Receives First Patent for Preventing and Repairing Damage to Cardiac Tissue Before, During and After Injury
Patents - Salix Pharmaceuticals Licenses DIACOL to Dr. Falk Pharma in Europe
Patents - Sigma Announces an Expansion of Its Generic Pipeline Access Agreement With Arrow Group
Patents - Since 2005, the Growth Rate of Global Pharmaceutical Market Mainly Pulled By North America Slowed Down To Below 10%
Patents - The Market for Chinese Traditional Patent Medicine Increased by 10.06% to Total RMB 37.205 Billion
Patents - United States Patent and Trademark Office Issues Cyberkinetics' Patent for Andara OFS Therapy
Patents - University Lab Technologies Will Launch Revolutionary New Product, Arthroleve, in Las Vegas
Patents - Vical Expands Testing of Vaxfectin Adjuvant to U.S. Navy Malaria Vaccine Program
Patents - Vitrolife: Notice of Allowance for Steen Solution Patent In USA
Renhuang Pharmaceuticals, Inc. - Renhuang Pharmaceuticals Appoints Magnus Moliteus, Former CEO of Pharmacia Inc., as an Independent Director to its Board of Directors
Research and Markets Ltd. - Future Trends and Developments in the Pharmaceuticals Industry in the United States
Research and Markets Ltd. - Research & Markets: Gilead Sciences Acquisitions of Myogen and Corus Pharma Has Significantly Expanded the Scope of Their Research Efforts
Restless Legs Syndrome - Schwarz Pharma's Rotigotine CDS will Overtake GlaxoSmithKline's Requip as the Clinical Gold Standard for the Treatment of Restless Legs Syndrome by 2009
Retinitis Pigmentosa - Neurotech Initiates two Phase II/III Clinical Trials of NT-501 for the Treatment of Retinitis Pigmentosa
RxHub, LLC - RxHub Network Solutions Selected to Assist CCHIT
Schizophrenia - FDA Approves New Dose of RISPERDAL CONSTA for Schizophrenia Treatment
Thomson Scientific - Thomson Scientific Publishes 'Who is Making the Biggest Splash?' - a Quarterly Review of Scientific Literature on Drugs and Therapies
Thrombosis - CINVENTION and Relisys Medical Devices Enroll First Patients in Clinical Trial of the Corel + C Drug-Eluting Stent
Thrombosis - Othera Pharmaceuticals Announces Upcoming Presentation Based Upon Expanded Understanding of Lead Compound Mechanism of Action
Transfusion Medicine - Baxter Reports Strong First Quarter Financial Results and Boosts Full-Year Outlook
Travel Health - Ace Biosciences and Naval Medical Research Center Begin Campylobacter Trial Following Ind Approval By Us Fda
Trimeris, Inc. - Trimeris Reports First Quarter 2007 FUZEON Sales Results
Type 1 Diabetes - Diobex Raises $24 Million Series B Financing Led by Inventages Venture Capital
Ultrasound - Vascular Solutions launches Vari-Lase Bright Tip laser fiber
Urology - AEterna Zentaris Reports First Patients Treated with Cetrorelix for Phase 3 Program in BPH
Acne Vulgaris - New research on acne vulgaris in adolescents from Wake Forest University, Department of Dermatology summarized
Actinic Keratosis Therapy - Reports on actinic keratosis therapy findings from University of Brescia provide new insights
Addiction Medicine - New addiction medicine study findings recently were published by researchers at Ohio State University, College of Social Work
Aging - Findings from University of Copenhagen, Institute of Public Health provide new insights into aging
Aging - University of Alabama, Education and Clinical Center describes research in aging
Anemia Immunology - Findings from Emory University, Emory Vaccine Center broaden understanding of anemia immunology
Anesthesia - New anesthesia research reported from Medical School, Department of Anesthesiology
Anesthesia - Studies from Edith Wolfson Medical Center, Department of Anesthesia provide new data on anesthesia
Anesthesia - Study findings from Adnan Menderes University broaden understanding of anesthesia
Angiology - Research results from Harold Wood Hospital, Department of Clinical Biochemistry update knowledge of angiology
Angiology - Scientists at Medical University of Graz, Department of Ophthalmology release new data on angiology
Angiotensins - Scientists at School of Medicine, Division of Cardiovascular Medicine describe research in angiotensins
Aortic Stenosis Therapy - New aortic stenosis therapy study results from Aker University, Division of Cardiology described
Arthritis Therapy - Research from University of California broadens understanding of arthritis therapy
Asthma Epidemiology - Recent findings from University of Cambridge highlight research in asthma epidemiology
Asthma Risk Factors - Scientists at Kaohsiung Medical University, Institute of Public Health target asthma risk factors
Atelectasis - New atelectasis study findings reported from Southern University
Atherosclerosis Therapy - Data on atherosclerosis therapy reported by researchers at University of Southern California, Department of Neurology
Atorvastatin - Researchers at University Federal of Sao Paulo publish new data on atorvastatin
Atrial Fibrillation Risk Factors - Data on atrial fibrillation risk factors described by researchers at University of Newcastle-upon-Tyne
Atrial Fibrillation Therapy - Researchers from Northern General Hospital publish findings in atrial fibrillation therapy
Autism - Research results from Bispebjerg Hospital update understanding of autism in children
Autism - Studies from Kaiser Permanente, Division of Research provide new data on autism in children
Bariatrics - New bariatrics study findings have been reported by researchers at Madigan Army Medical Center, Department of Surgery
Biochemistry - Scientists at Wake Forest University detail research in biochemistry
Biochemistry - Studies from University of Groningen, Groningen Biomolecular Sciences and Biotechnology Institute have provided new data on biochemistry
Bioinformatics - Study findings on bioinformatics are outlined in reports from King Faisal Specialist Hospital and Research Center
Biomedical Engineering - New biomedical engineering findings from Alfa Institute of Biomedical Sciences described
Biomedical Engineering - Reports summarize biomedical engineering study results from Osaka University
